Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 11/2022

20-04-2022 | Liver Transplantation | Short Communication

Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors

Authors: S. Ali Montazeri, Cynthia De la Garza-Ramos, Andrew R. Lewis, Jason T. Lewis, Jordan D. LeGout, David M. Sella, Ricardo Paz-Fumagalli, Zlatko Devcic, Charles A. Ritchie, Gregory T. Frey, Lucas Vidal, Kristopher P. Croome, J. Mark McKinney, Denise Harnois, Sunil Krishnan, Tushar Patel, Beau B. Toskich

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2022

Login to get access

Abstract

Purpose

To verify the correlation between yttrium-90 glass microsphere radiation segmentectomy treatment intensification of hepatocellular carcinoma (HCC) and complete pathologic necrosis (CPN) at liver transplantation.

Methods

A retrospective, single center, analysis of patients with HCC who received radiation segmentectomy prior to liver transplantation from 2016 to 2021 was performed. The tumor treatment intensification cohort (n = 38) was prescribed radiation segmentectomy as per response recommendations identified in a previously published baseline cohort study (n = 37). Treatment intensification and baseline cohort treatment parameters were compared for rates of CPN. Both cohorts were then combined for an overall analysis of treatment parameter correlation with CPN.

Results

Sixty-three patients with a combined 75 tumors were analyzed. Specific activity, dose, and treatment activity were significantly higher in the treatment intensification cohort (all p < 0.01), while particles per cubic centimeter of treated liver were not. CPN was achieved in 76% (n = 29) of tumors in the treatment intensification cohort compared to 49% (n = 18) in the baseline cohort (p = 0.013). The combined cohort CPN rate was 63% (n = 47). ROC analysis showed that specific activity ≥ 327 Bq (AUC 0.75, p < 0.001), dose ≥ 446 Gy (AUC 0.69, p = 0.005), and treatment activity ≥ 2.55 Gbq (AUC 0.71, p = 0.002) were predictive of CPN. Multivariate logistic regression demonstrated that a specific activity ≥ 327 Bq was the sole independent predictor of CPN (p = 0.013).

Conclusion

Radiation segmentectomy treatment intensification for patients with HCC prior to liver transplantation increases rates of CPN. While dose strongly correlated with pathologic response, specific activity was the most significant independent radiation segmentectomy treatment parameter associated with CPN.
Appendix
Available only for authorised users
Literature
3.
go back to reference Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17–29. https://doi.org/10.1016/S2468-1253(20)30290-9. Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17–29. https://​doi.​org/​10.​1016/​S2468-1253(20)30290-9.
5.
go back to reference DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US Multicenter HCC Transplant Consortium. Ann Surg. 2020;271(4):616–24. https://doi.org/10.1097/SLA.0000000000003253. DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US Multicenter HCC Transplant Consortium. Ann Surg. 2020;271(4):616–24. https://​doi.​org/​10.​1097/​SLA.​0000000000003253​.
12.
go back to reference Field A. Discovering statistics using IBM SPSS statistics 5th Ed. 2018. Field A. Discovering statistics using IBM SPSS statistics 5th Ed. 2018.
13.
go back to reference Hahs-Vaughn, D. LomaX R. An introduction to statistical concepts. 2013. Hahs-Vaughn, D. LomaX R. An introduction to statistical concepts. 2013.
14.
go back to reference Field A. Discovering statistics using IBM SPSS statistics. 2013. Field A. Discovering statistics using IBM SPSS statistics. 2013.
15.
go back to reference De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical safety of ablative yttrium-90 radioembolization for hepatocellular carcinoma as a function of percent liver treated. J Hepatocell Carcinoma. 2021;8:861–70. https://doi.org/10.2147/JHC.S319215. De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical safety of ablative yttrium-90 radioembolization for hepatocellular carcinoma as a function of percent liver treated. J Hepatocell Carcinoma. 2021;8:861–70. https://​doi.​org/​10.​2147/​JHC.​S319215.
Metadata
Title
Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors
Authors
S. Ali Montazeri
Cynthia De la Garza-Ramos
Andrew R. Lewis
Jason T. Lewis
Jordan D. LeGout
David M. Sella
Ricardo Paz-Fumagalli
Zlatko Devcic
Charles A. Ritchie
Gregory T. Frey
Lucas Vidal
Kristopher P. Croome
J. Mark McKinney
Denise Harnois
Sunil Krishnan
Tushar Patel
Beau B. Toskich
Publication date
20-04-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05776-y

Other articles of this Issue 11/2022

European Journal of Nuclear Medicine and Molecular Imaging 11/2022 Go to the issue